Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

rezivertinib × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1269 Specimen Handling 900 Carboplatin 822 Magnetic Resonance Spectroscopy 813 Cyclophosphamide 806 Cisplatin 705 Nivolumab 697 Paclitaxel 619 Radiotherapy 607 Gemcitabine 567 Biopsy 544 Bevacizumab 475 Dexamethasone 446 fludarabine 392 Docetaxel 381 venetoclax 379 Oxaliplatin 365 Fluorouracil 363 Capecitabine 357 atezolizumab 350 Rituximab 344 durvalumab 336 Drug Therapy 331 Doxorubicin 319 Radiosurgery 315 Ipilimumab 312 Blood Specimen Collection 311 Standard of Care 310 Pemetrexed 308 Radiation 284

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06955325 2025-05-06

UPLIFT

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡